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Vasohibin-1 mediated detyrosination of endothelial microtubules is selectively required 
for adequate behaviour of venous secondary sprouting and subsequent formation of 





Previous studies have shown that Vasohibin-1 (Vash-1) is stimulated by VEGFs in 
endothelial cells and that its overexpression interferes with angiogenesis in vivo. 
Recently, Vasohibin-1 was found to mediate tubulin detyrosination, a post-translational 
modification that is implicated in many cell functions, such as cell division. Here we 
used the zebrafish embryo to investigate the cellular and subcellular mechanisms of 
Vash-1 on endothelial microtubules during formation of the trunk vasculature. We show 
that microtubules within venous-derived secondary sprouts are strongly and selectively 
detyrosinated in comparison with other endothelial cells, and that this difference is lost 
upon vash-1 knockdown. Vasohibin-1 depletion in zebrafish specifically affected 
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secondary sprouting from the posterior cardinal vein, increasing both the number of 
sprouts and endothelial cell divisions. We show that altering secondary sprout numbers 
and structure upon vash-1 depletion leads to a failure in the development and 






Blood vessel formation and patterning is essential for tissue growth and homeostasis 
in vertebrate development and physiology. Endothelial cells arising from the lateral 
plate mesoderm in early embryonic development initially coalesce at the midline to 
form the first arterial and venous structures. Subsequent sprouting angiogenesis and 
remodelling expands and shapes the vascular tree throughout the developing embryo 
(Hogan & Schulte-Merker, 2017; Potente et al., 2011). Complex morphogenic and cell 
differentiation processes orchestrate formation of arteries, veins, and capillaries, as 
well as of the lymphatic vascular system.  
The trunk vasculature in zebrafish embryos has served both angiogenesis and 
lymphangiogenesis research as a powerful model to observe, manipulate and 
mechanistically understand relevant cellular processes and their molecular control 
(Gore et al., 2016; Hogan & Schulte-Merker, 2017).  Following the initial assembly and 
lumenisation of the dorsal aorta (DA) and posterior cardinal vein (PCV), the 
intersegmental vessels (ISV) form by sprouting. This first wave of sprouting emerges 
from the DA at 22 hours post fertilization (hpf), with bilateral sprouts along the somite 
boundaries to form the first vascular loops (Isogai et al., 2003; Kohli et al., 2013). A 
second wave of sprouting emerges from the PCV at 34hpf (Koltowska et al., 2015; 
Nicenboim et al., 2015; Yaniv et al., 2006), remodelling some ISVs into veins (Geudens 
et al., 2010; Yaniv et al., 2006) and forming parachordal lymphangioblasts (PLs) at the 
midline. The PLs subsequently migrate and branch to shape the mature lymphatic 
system of the zebrafish trunk including the thoracic duct (TD) and the dorsal 
longitudinal lymphatic vessel (DLLV) (Küchler et al., 2006; Yaniv et al., 2006).  
Although primary and secondary sprouts appear morphologically similar, with tip and 
stalk cells and acto-myosin cellular protrusions, they are driven by distinct growth 
factors and downstream signalling cascades. In particular, arterial sprouting involves 
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VEGF-A, VEGFR2, PLCγ , and on the other hand venous/lymphatic sprouting is 
controlled by VEGF-C, VEGFR3, CCBE (Hogan & Schulte-Merker, 2017).  
Recent reports have highlighted the importance of actin-based in endothelial cell (EC) 
dynamics during morphogenesis (Gebala et al., 2016; Lamalice et al., 2007; Phng et 
al., 2015). Microtubules however, although critically involved in cell division (Belmont 
et al., 1990), polarity (Siegrist & Doe, 2007) and vesicle transport mechanisms (Vale, 
2003), have received little attention in vascular biology research. This is despite their 
relevance for tumour angiogenesis and vessel maintenance, as microtubule targeting 
drugs used for cancer therapy are anti-angiogenic and/or stimulate the collapse of 
tumour vasculature (Hayot et al., 2002; Kruczynski et al., 2006; Schwartz, 2009; Shi et 
al., 2016; Tozer et al., 2002). The mechanisms behind this phenomenon are not 
understood. Microtubules are unbranched cytoskeleton polymers made of α- and β-
tubulin heterodimers that assemble in a directional manner to shape a polarised hollow 
tube. α-tubulin carries a tyrosine residue that can be removed post-translationally by 
the carboxylpeptidase Vasohibin-1 (Vash-1) (Aillaud et al., 2017; Nieuwenhuis et al., 
2017), in a reaction referred to as tubulin detyrosination. Tubulin detyrosination is 
crucial for neuronal development (Erck et al., 2005), cell division (Barisic et al., 2015; 
Liao et al., 2019)  and influences vesicle transport (Dunn et al., 2008). Interestingly, 
VASH-1 was previously identified as a VEGFA-inducible gene in vitro (Abe & Sato, 
2001) and is expressed in the developing  endothelium in vivo (Hosaka et al., 2009; 
Shibuya et al., 2006; Watanabe et al., 2004). Viral overexpression as well as VASH-1 
protein administration experiments in vitro and in vivo show that VASH-1 inhibits 
angiogenesis and reduces vessel diameter (Hosaka et al., 2009; Kern et al., 2009). 
Conversely, VASH-1 knockout mice exhibited more vascularised tumours (Hosaka et 
al., 2009) and increased angiogenesis in the ear skin injury model (Kimura et al., 2009). 
Although these studies demonstrated that VASH-1 is necessary for controlling 
angiogenesis in a tumour and injury onset in vivo, they predated the discovery of 
VASH-1 as a microtubule modifying enzyme. Thus, the role of microtubule 
detyrosination and VASH-1 in particular in the context of in vivo angiogenesis remains 
unknown. 
 
Here, we use the zebrafish trunk vasculature to characterise microtubule 
detyrosination and the effects of vash-1 knockdown on secondary sprouting and 
lymphatic development. Using high-resolution live imaging, combined with 
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immunofluorescence and gene expression analysis, we find that endothelial tubulin is 
predominantly detyrosinated in secondary sprouts. vash-1 knockdown causes 
morphogenic defects in secondary but not primary sprouts, impeding proper lymphatic 
development. Mechanistically, vash-1 loss-of-function leads to increased EC division 
within secondary sprouts and supernumerous secondary sprouts that fail to adopt 
lymphatic lineage identity. We propose that Vash-1 controlled endothelial tubulin 
detyrosination supports differential endothelial specification during cell division and 
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MATERIAL AND METHODS 
 
Zebrafish maintenance and transgenic lines 
Zebrafish (Danio rerio) were raised and staged as previously described (Kimmel et al., 
1995). For growing and breeding of transgenic lines, we complied with regulations of 
the animal ethics committees at MDC Berlin (Aleström et al., 2019). The following 
transgenic lines were used: Tg[fli1a:EGFP]y1 (Lawson & Weinstein, 2002) labels all 
ECs, Tg[fli1a:nEGFP]y7 labels all EC nuclei (Roman et al., 2002), Tg[kdr-l:ras-
Cherry]s916 (Hogan, Bos, et al., 2009) labels EC membrane, Tg[fli1ep:EGFP-DCX] 
(Phng et al., 2015) labels endothelial doublecortin, a microtubule associated protein. 
 
Immunofluorescence staining and imaging 
Embryos were treated with PTU in later stages than 24hpf to prevent pigment 
formation. Embryos were fixed with 4% Paraformaldehyde (PFA) for 10h at 4°C, and 
kept for a maximum of 4 days in PBTX at 4°C. Embryos were permeabilised by 
dehydrating them in a crescent methanol concentrations solutions - 25%, 50% and 
75% -, incubated for 1h at -20°C, before being rehydrated in descending methanol 
concentration solutions - 75%, 50% and 25% -, 3 times washed with PBTX and post-
fixed with 4% PFA for 10 minutes (min). The embryos were incubated for 2 hours in 
blocking buffer (10% horse heat inactivated serum, 1% DMSO, 100mM maleic acid in 
0,1% PBTX) at room temperature.  Embryos were incubated at 4°C overnight with 
primary antibodies (indicated below) diluted in blocking buffer. The embryos were then 
washed with a solution containing 1% DMSO and 100mM maleic acid in 0,1% PBTX 
at room temperature and blocked again for 30 min before being incubated with 
secondary antibodies diluted in blocking buffer overnight. Embryos were washed again 
in 1% DMSO and100mM maleic acid in 0,1% PBTX, fixed with PFA 4% for 30 min at 
room temperature, washed again and stored at 4 C in PBST until being mounted in 
glycerol and stored at 4°C. 
Primary antibodies used were anti-detyrosinated tubulin (1:600, rabbit, home-made 
(Liao et al., 2019), anti-GFP FITC conjugate (1:200, mouse, Abcam, ref. ab6662). 
Secondary antibody used was Invitrogen Alexa 568 against rabbit (1:200 donkey, ref. 
A10037). All antibodies were diluted in the blocking buffer, described in the previous 
paragraph. 
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Live imaging and analysis 
Embryos were dechorionated and anaesthetised with 0,014% (1x) tricaine 
methanesulfonate (MS-222, Sigma-Aldrich). Embryos were then mounted in 0,8% low 
melting point agarose (Life Technologies) containing 0,014% tricaine and immersed in 
E3 buffer containing 0,014 % tricaine and 0,003% PTU when indicated. Live embryos 
were imaged with an upright 3i Spinning Disk Confocal using Zeiss Plan-Apochromat 
20x and 40x /1.0 NA water dipping objectives. Image processing was performed using 
Fiji software (Schindelin et al., 2012). XY drifts were corrected using the MultiStackReg 
plugin (B. Busse, NICHD).  
 
Secondary sprout and 3-way connection parameters 
The number of secondary sprouts was quantified in 15 minute time-lapse movies from 
24 to 48 hpf, in Tg[kdrl-l:ras-Cherry,fli1a:nEGFP] embryos. The number of nuclei was 
assessed in each secondary sprouts just prior to connection to the pre-existing ISV. 
Cell divisions in secondary sprouts were quantified by adding nuclear (nEGFP) 
divisions from the time of emergence from the PCV, until the resolution of the 3-way 
connection with pre-existing ISVs. The duration of the 3-way connection was quantified 
in the same embryos from the moment it connects to the primary ISV and lumenises 
until the 3-way connection is resolved.  
  
Lymphatics: PLs and TD quantifications 
PLs and TD were quantified by examining Z-stacks of 52 hpf and 4 days post 
fertilization (dpf) Tg[fli1a:EGFPy1] embryos and counting presence/absence in each 
somite.  The number of PLs associated with venous ISVs, identified by a connection 
to the venous ISV, were identified at 52 hpf in vash-1 morphants and control siblings. 
 
Immunofluorescence quantifications 
Substacks containing single ISVs were cropped manually from images of whole 
Tg[fli1ep:EGFP-DCX] embryos stained with dTyr antibody. To estimate the 
background, which varied locally due to autofluorescence of the embryos, each image 
was filtered with a large Gaussian filter (radius = 50 pixels) and subtracted from the 
original image. A maximum intensity projection of the DCX channel was used to 
manually segment endothelial microtubules, with particular care to exclude the 
neurons. The resulting mask was applied to background corrected, sum intensity 
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projections of DCX and dTyr channels. Mean intensity was extracted and plotted, to 
quantify the normalised and direct differences of tubulin detyrosination intensity in 
different experimental groups. The analysis was performed in Fiji.  
 
Statistical analysis 
Zebrafish embryos were selected on the following pre-established criteria: normal 
morphology, beating heart, and flowing blood. The experiments were not randomised 
and the investigators were not blinded during experiment and analysis. All morphant 
embryos analysed in this project exhibited no apparent visual phenotype. 
 In order to decide if a parametric or non-parametric test should be used to compare 
different experimental groups, we assessed whether the population was normally 
distributed, by Anderson-Darling test. If so, t-test and regular ANOVA were performed, 
if not, Mann-Whitney and Kruskall-Wallis tests were performed. 
 
Cell isolation for gene expression analysis 
Tg[fli1a:nEGFP]y7 were outcrossed and their embryos collected. Negative embryos 
were also collected under the stereoscope, to serve as GFP negative control siblings 
during cell sorting. Embryos were treated with 0,003% PTU when older than 24hpf. 
The embryos were dechorionated by adding pronase (1mg/ml) for 15 min, 
subsequently washed in E3 buffer, and anaesthetised with 0,16 mg/mL tricaine 
methanesulfonate (Sigma). 250 embryos were transferred to a 1.5ml tube and the yolk 
sac was removed by 2 rounds of centrifugation (or until the solution was clear) with 
Calcium ringer solution at 2000rpm at 4°C for  5 min. The embryos were then 
resuspended in 1ml of Protease solution (0,07mg/ml of Liberase in DPBS- 
Thermofisher)  with 0,4U/ml DNAse I (Invitrogen). The embryos were dissociated at 
28°C for 10min on a rotator (or until the embryos appeared visually digested to a single 
cell solution), pipetting up and down with a 200 mL tip every 4-5 min. The reaction was 
stopped by placing the cell solution on ice and adding CaCl2 to a final concentration of 
1-2mM with 0,5% FBS in DPBS. The cells were centrifuged at 2000rpm for 5 min at 
4°C, the supernatant was discarded, and the pellet resuspended in 1ml resuspension 
solution (DPBS with 2mM EDTA, 0,4U/ml DNAseI and 0,5%FBS) to avoid cells 
clumping together. The cells were passed through a 40μM strainer into to a 50ml falcon 
tub, following a pre-wash of the strainer with 500μl of the resuspension solution. 
Another 500μL of the resuspension solution was added to the filter to remove any cells 
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left.  The cells were centrifuged at 2000rpm for 5 min at 4°C and resuspended in 500μl 
of DPBS+EDTA solution. The cell solution was transferred to a 5ml polypropylene 
(Falcon) dedicated test tube and kept on ice until sorting with a FACSAria™ III Sorter 
(BD). Cells were sorted and filtered against triplets and droplets. Negative control cells 
from negative nEGFP siblings were used to define the GFP+ collection window, to filter 
against auto-fluorescence. nEGFP positive and negative cells from green 




Cell lysis suspension was vortexed for 15 seconds (s), spun down, and incubated at 
room temperature for 5 min. 0,5μl glycoblue, a nucleic acid coprecipitant was added to 
the lysed solution to aid visualising the precipitated RNA. 50μl chloroform was added 
to each tube, which were shaken vigorously for 15 seconds, and incubated at room 
temperature for 5 min. Tubes were centrifuged at 12.000RPM for 15 min at 4°C. RNA 
is present in the transparent supernatant. The supernatant was carefully pipetted to a 
LoBind eppendorf tube. 125μl was added to the aqueous phase and the tube was 
shaken vigorously for 15s. The solution was incubated at -20°C overnight. The solution 
was then centrifuged at 12.000RPM for 10 min for 4°C and a small blue RNA pellet is 
visible at this point. The supernatant was then removed, leaving the RNA pellet that  
was washed with 500μl of 75% ethanol, shaken and centrifuged at 7.500RPM for 5 
min at 4°C. The supernatant was discarded and the pellet air dried until no liquid was 
left. The pellet was resuspended in 13μl of DEPC water and the concentration and 
purity was measured in a Nanodrop 2000 (ThermoScientific) and the reverse 
transcription proceeded for samples presenting with a  an RNA concentration above  
20ng/μl and a 260/280 purity higher than 1.8.  The kit Superscript IV First-Strand cDNA 
synthesis reaction (ThermoFisher) was used for the reverse transcription reaction, 
using random hexamer primers. The reaction was incubated for 1 hour. The final 
reaction was diluted 1:10 and kept at -20°C. 
 
qPCR 
The primers were designed using Primer blast 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) to have Tm of 60°C and to span exon-
exon junctions to avoid amplification of genomic DNA. Each reaction was set in a 20μL 
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volume, mix containing 10μl of SYBR-green qPCR mix (Roboklon), 0,8μl cDNA (1:50 
dilution), 0,45μl of carboxyrhodamine (ROX) and 0,25μl uracil-N-glycosylase (UNG) 
from Roboklon and primers to a final concentration of 300uM, three technical replicates 
of each sample were added. Amplification was performed in triplicates in 384 well 
plates (Applied Biosystems) with the following thermal cycling conditions: initial UDG 
treatment 50°C for 10 min, followed by 40 cycles of 15 s at 95°C and 60 s at 60°C. 
Control reactions included a no template control (NTC). qPCR was performed in 
Quantstudio6Flex machine (Life-technologies). Amplification curves were analysed to 
confirm the presence of a single PCR product, and outliers excluded when one of the 
Ct values was very different from the other two. qPCR data was analysed by using the 
Pfaff method (Pfaffl, 2001) that integrates primer amplification efficiency, determined 
by LinReg software (Ruijter et al., 2009). Samples were normalised against 4 
endothelial housekeeping genes- rpl13, rps29, hprt1 and ef2a. The geometric average 
of the housekeeping genes was used for normalisation of gene expression (Coxam et 
al., 2014). 
 
Primer name Sequence 
vash-1-1 fw GGGACATGAGGCTCAAGATTGG 
vash-1-1 rev GTCGCTCTGGCTGTTCTTGC  
vash-1-2 fw ATCATTAACAGGGGCGGCCT 
vash-1-2 rev GGTACTGGAATCTTGGGCAGGT 
rpl13 fw CATCTCTGTTGACTCACGTCG 
rpl13 rev CATCTTGAGCTCCTCCTCAGTAC 
rps29 fw TTTGCTCAAACCGTCACGGA 
rps29 rev ACTCGTTTAATCCAGCTTGAC 
hprt1fw ATCATGGACCGAACTGAACG 
hprt1rev AGCGATCACTGTTGCGATTA 
ef2a fw CTGGAGGCCAGCTCAAACAT 
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ef2a rev ATCAAGAAGAGTAGTACCGCTAGCATTAC 
 
 
Protein extraction for protein analysis 
35 embryos were dechorionated by adding pronase (1mg/ml) and anaesthetised with 
0,16 mg/mL tricaine methanesulfonate (Sigma). Yolk sacs were removed with 2 rounds 
of centrifugation in Calcium ringer solution at 2000rpm, 4°C, for 5 min and removed all 
liquid until only a dry pellet of embryos is left in the tube. Pellets were fast frozen with 
liquid nitrogen and kept at -80°C for at least 20min. Protein extraction procedure 
included adding 40 μl of lysis buffer (1M Tris-HCl,0,5M EDTA, 10% Brij 96, 10% NP-
40) and 0,4 μl of protease inhibitor cocktail (ThermoFisher), homogenise it with a pestle 
(Starlab), centrifugation at 4°C for 15 min. The concentration of the proteins 
extracts  were measured with the BCA protein assay kit (ThermoFisher). 
 
Western Blot 
50μg of the lysates were mixed with reducing sample buffer (1:4) and heated for 5 min 
at 95°C to denaturate proteins. The protein were electrophoresised for 1h at 150V and 
subsequently transferred onto MtOH activated polyvinylidene fluoride membranes (GE 
Healthcare). Equal loading was assessed  using Ponceau red solution. Membranes 
were blocked with Blocking solution (5% nonfat dry milk in TBS-T) for 1,5h at room 
temperature and then incubated with primary antibody against Vash-1, overnight at 
4°C (1:500, Proteintech, ref. 12730-1-AP). After incubation with primary antibody, the 
membranes were washed 4 times in TBS-T and then incubated with secondary 
antibodies for 1h (1:4,000; GE Healthcare) and washed 3 times with TBS-T. 
Immunodetection was performed using a chemiluminescence kit (SuperSignal West 
Dura; Pierce), and bands were developed using the Las-4000 imaging system. After 
initial immunodetection, membranes were stripped of antibodies by using the Stripping 
kit (ThermoFisher) at 56°C for 40min and re-probed with anti– beta-actin antibody for 
1h (1:1000, Sigma, ref. A5441). 
 
Morpholino experiments 
Morpholino against plcγ  was used as previously described (Hogan, Bos, et al., 2009). 
Dosage curves were used to find the appropriate dosage for  injection (indicated in the 
table below). The injection mix was done with 4% phenol red, and 1nl was injected at 
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a 1-cell stage. The amount of Control MO injected was the same as the total amount 
of experimental MO injected. 
  
Morpholino against Sequence 5’ to 3’ Amount injected 
vash-1 Morpholino 1 ATTAATCTGAGGAGCACACGGCAGT 3ng 
vash-1 Morpholino 2 GTAACTGAGCCATCGCAGGAGTTAA 5ng 
plcγ  Morpholino ATTAGCATAGGGAACTTACTTTCG 
 
10ng 
Control Morpholino CCTCTTACCTCAGTTACAATTTATA 
 
The same as experimental MOs 
 
Rescue experiment 
vash-1 full length cDNA (EMSEMBL ENSDART00000143819.3) was designed and 
synthesised by GenScript. TA overhangs were added by incubating the insert for 10 
min at 72 °C with 50mM DNTPs and Taq polymerase (NEB), in order to perform TA 
cloning into a PCR4 TOPO vector (ThermoFisher). Integration was confirmed by 
sequencing. In order to transcribe the cDNA into RNA, the construct was linearised by 
NotI and the cDNA was transcribed for 4 hours by Megascript kit (LifeTechnologies) 
using the T3 promoter. The RNA was purified by Lithium-Chloride precipitation to a 
concentration of 500ng/μl. Aliquots were kept at -80°C until further usage.  For rescue 
experiments, 1nl of 150pg RNA was injected, in embryos already injected with MOs 
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Vasohibin-1 is highly expressed in zebrafish endothelial cells in vivo 
To study the role of Vash-1 driven microtubule detyrosination in angiogenesis in 
zebrafish, we first investigated the conservation of zebrafish and human variants of 
Vash-1 (Fig. 1A,B) with CLUSTAL O (Uniprot). The analysis predicted 65,24% 
similarity between zebrafish and human Vash-1 (Fig. 1A), including the previously 
identified residues necessary for tubulin tyrosine and glutamate recognition, and the 
catalytic active site Cys-His-Ser triad (Adamopoulos et al., 2019; Nieuwenhuis et al., 
2017; Sanchez-Pulido & Ponting, 2016) (Fig. 1B). RT-qPCR on RNA extracted from 
ECs sorted from Tg[fli1a:nEGFP]y7  embryos at 24 and 48 hours post fertilization (hpf) 
showed dynamic expression of vash-1 during zebrafish development. During the 
sprouting phase (24hpf), vash-1 expression was 5-7 times higher in endothelial than 
in non-ECs, decreasing at 48 hpf (Fig. 1C-D). Although these results are not significant, 
they were independently confirmed with a second primer set. 
 
Vasohibin-1 carboxypeptidase function is conserved in zebrafish. 
A splice-site interfering morpholino (MO) targeting the intron3-exon4 boundary of 
nascent vash-1 RNA (Fig. 2A) efficiently decreased the expression of vash-1 in 
zebrafish embryos (Fig. 2B). Injections of MO against vash-1 and control MO were 
performed in the Tg[fli1ep:EGFP-DCX] zebrafish line, selectively labelling endothelial 
microtubules by expression of GFP-tagged microtubule-binding protein doublecortin 
(Phng et al., 2015). Tubulin detyrosination was assessed by antibody staining against 
the glutamate residue of α-tubulin that becomes available after the tyrosine residue is 
removed by Vash-1 (Fig. 2C). Microtubules detected by this antibody are referred to 
as detyrosinated microtubules (dTyr). Whereas control embryos exhibited a high 
intensity array of detyrosinated tubulin in the neural tube, centrosomes, motoneurons 
(Fig. 2 D,E) and ECs (Fig. 2E’, arrowhead), vash-1 knockdown (KD) embryos showed 
strongly diminished labelling of these structures (Fig. 2F,G). In particular, endothelial 
labelling was absent following vash-1 KD (Fig. 2G’). Quantification of the ratio between 
dTyr tubulin and DCX (endothelial microtubules) signal intensities and of the 
detyrosination signal alone (Fig. 2H-I) confirmed that detyrosination of endothelial 
microtubules is significantly reduced in vash-1 KD ISVs (dTyr/DCX= 0,24±0,01). in 
comparison with control ISVs (dTyr/DCX= 0,35±0,03)  However, The DCX-GFP signal 
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remained unchanged, suggesting that the overall microtubule cytoskeleton was not 
affected by vash-1 KD (Fig. 2J). 
 
Vasohibin-1 regulates secondary sprouting through control of endothelial cell 
divisions 
Live-imaging of sprouting angiogenesis in Tg[kdrl-l:ras-Cherry, fli1a:nEGFP] embryos 
showed comparable primary sprouting and intersegmental vessel (ISV) network 
formation in control and vash-1 KD embryos (Fig. 3A-F). Secondary sprouting however 
progressed abnormally in vash-1 KD embryos with 1.5 times more secondary sprouts 
(Fig. 3F,G. Control embryos with 2,8±0,6 and vash-1 embryos with 4,4±0,3). The vash-
1 KD secondary sprouts exhibited an increased number of ECs (Fig. 3H,J) compared 
to control secondary sprouts (Fig. 3I).  Quantifying nuclear divisions from movies 
acquired between 30 and 70 hpf at 15 minute time resolution revealed 3 times more 
nuclear divisions in the vash-1 KD secondary sprouts than in controls (Fig. 3K). 
Furthermore, the transient 3-way connections (Fig. 3L-M) that regularly form during 
vein/lymphatic development (Geudens et al., 2019)  took on average 1.5 times longer 
to resolve (Fig. 3N, control takes 6,0h±2,3 and vash-1 KD takes 11,3h±1,9). These 
results suggest a potential defect in the vasculature that forms by secondary sprouting.  
 
Endothelial microtubules are selectively detyrosinated in secondary sprouts.  
Immunostaining against detyrosinated tubulin (dTyr) in fixed, uninjected 
Tg[fli1ep:EGFP-DCX] embryos at 24 and 34 hpf (Fig. 4A-F) revealed that, although the 
microtubules of the primary sprouts showed little to no staining (Fig. 4B,C,C’), the 
microtubules of the vast majority of secondary sprout cells were strongly labelled (Fig. 
4E,F,F’). Quantification of fluorescence signal in endothelial microtubules from 
secondary sprouts was challenging due to the overlap of ECs from the primary sprouts. 
To mitigate this, we took advantage of the fact that zebrafish phospholipase C-γ (plcγ) 
morphants, that exhibit no primary sprouting and subsequent arterial ISV formation 
since the VEGFR2-Plcγ-signalling pathway is activated and necessary only for primary 
spouting (Hogan, Bos, et al., 2009). Secondary sprouting occurs normally in these 
embryos, and the absence of ISVs facilitates the measurement of signal intensities in 
secondary sprouts (Fig. 4G-I). Quantification of the signal intensity ratio between 
detyrosinated tubulin and DCX (endothelial microtubules) confirmed a 3-fold higher 
signal in secondary sprouts of plcγ morphants than in primary sprouts of control 
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morphants (Fig. 4J. primary sprouts show dTyr signal intensity of 1,1±0,07 and 
secondary sprouts of 2,7±0,35). 
 
Vasohibin-1 regulates formation of trunk lymphatic vasculature. 
Closer examination of Tg[fli1a:EGFPy1,kdr-l:ras-Cherry] embryos further revealed 
defects in the formation of lymphatic structures. At 52 hpf, the number of PLs emerging 
as lymphatic progenitors at the horizontal myoseptum was dramatically reduced in 
vash-1 KD compared to control embryos (Fig. 5A-C). In addition, PLs in vash-1 
morphants frequently appeared connected to the venous ISVs, unlike in sibling 
controls (Fig. 5 D). Occasionally at 52 hpf and later in development at 4 dpf, we 
observed kdrl-mCherry positive, lumenised connections between ISVs, formed in the 
horizontal myoseptum (Fig. 5B,F,F’, arrow heads), suggesting they are aberrant 
vascular shunts. PLs are transient structures that normally form by sprouting of a 
subset of the secondary sprouts (Hogan, Bos, et al., 2009; Koltowska et al., 2015; 
Yaniv et al., 2006). From their initial position at the horizontal myoseptum, they migrate 
ventrally to shape the main trunk lymphatic vessel, the thoracic duct (TD) (Bussmann 
et al., 2010). The TD can be detected as an eGFP positive and mCherry negative 
vessel that locates between the DA and the PCV at 4 dpf. Control embryos showed 
almost complete TD formation along the trunk, whereas in vash-1 morphants the TD 
was mostly absent (Fig. 5 E’,F’’). Quantification revealed a significant reduction in the 
percentage of somites with a TD fragment in vash-1 KD embryos (20%±4,18) 
compared to controls (78%±4,4) (Fig. 5 G).  
The observation of the reduced number of PLs in the vash-1 morphants was confirmed 
by a second MO targeting a different splicing region of nascent vash-1 mRNA (Fig. 
5H,I). Finally, we were able to partially rescue the loss of PLs in vash-1 morphants by 
co-injection with VASH-1 mRNA (Fig. 5J), supporting our hypothesis that the observed 
lymphatic defects are indeed caused by loss of Vash-1 function.   
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Tubulin detyrosination is important for several differentiation events and 
developmental processes, such as myogenesis (Chang et al., 2002; Gundersen et al., 
1989; Kerr et al., 2015) and neurogenesis (Aillaud et al., 2017; Erck et al., 2005), 
although the cellular mechanisms behind this are poorly understood. Vash-1, an 
angiogenesis inhibitor, was recently identified  as the catalyst of this reaction (Aillaud 
et al., 2017; Nieuwenhuis et al., 2017). The cellular mechanisms behind the vascular 
phenotypes upon Vash-1 loss- and gain-of-function are not well understood. 
In this study, we identified Vash-1-mediated microtubule detyrosination as a cellular 
mechanism of relevance for the control of EC sprouting from the PCV and the 
subsequent formation of lymphatic vessels in the zebrafish trunk. We showed that 
microtubules in secondary sprouts are particular in that they are selectively highly 
detyrosinated. We further show that vash-1 depletion reduces the level of microtubule 
detyrosination and negatively affects secondary sprouting. Upon vash-1 KD, 
supernumerous secondary sprouts emerge from the PCV. These sprouts contain more 
endothelial nuclei, as ECs divide almost twice as often as in control conditions. These 
results suggest that Vash-1-driven microtubule detyrosination limits excessive venous 
EC sprouting and proliferation during lympho-venous development in zebrafish.  
 
Although the cellular mechanisms of primary and secondary sprouting in zebrafish 
appear very similar, with tip cell selection and guided migration and stalk cell 
proliferation, secondary sprouting utilises alternative signalling pathways and entails a 
unique specification step that establishes both venous ISVs and lymphatic structures. 
Secondary sprouting in zebrafish is triggered by Vegfc and activation of its receptor 
Flt4 in a subpopulation of ECs in the PCV (Bussmann et al., 2010; Hogan, Herpers, et 
al., 2009) that increase prox1 expression prior to a cell division (Koltowska et al., 2015; 
Nicenboim et al., 2015). This cell division is thought to lead to asymmetric identity 
acquisition by the daughter cells, as one cell remains in the PCV while the other cell 
sprouts from the PCV to form a venous ISV (vISV) or become a lymphatic progenitor 
(Koltowska et al., 2015; Nicenboim et al., 2015). The specification of vISVor lymphatic 
progenitor is influenced by the levels of prox1 expression, with high expression thought 
to favour lymphatic specification by reinforcing flt4 expression (Koltowska et al., 2015). 
The observed increase of secondary sprouts in vash-1 morphants, as well as the 
supernumerous EC numbers within these sprouts and the reduced numbers of somites 
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with PLs, are consistent with defects in both the specification of daughter cells in the 
PCV and the specification of secondary sprouts into venous or lymphatic fates.  
 
Intriguingly, microtubule detyrosination has been shown to influence mitotic and 
meiotic spindle (Akera et al., 2017; Barisic et al., 2015; Liao et al., 2019), with emerging 
evidence for a potential role in asymmetric cell fate (Akera et al., 2017; Laloraya, 2018). 
Given the numerous examples of acquisition of different fates and/or behaviours by 
daughter cells after cell division in various developing tissues (Boone & Doe, 2008; G. 
et al., 2016; Yu et al., 2006), including ECs (G. et al., 2016; Koltowska et al., 2015; 
Nicenboim et al., 2015), it is tempting to speculate that the lack of detyrosinated 
microtubules interferes with this process during initiation and progression of secondary 
sprouting, such that endothelial daughter cells retain their undifferentiated state and 
fail to specialise into lymphatic ECs (LECs). Failure to differentiate under activated 
conditions is frequently associated with continued proliferation, also in ECs (Benedito 
et al., 2008; Siekmann & Lawson, 2007). A recent study reported a similar increase in 
secondary sprout numbers in the nova2 zebrafish mutants (Baek et al., 2019). Nova2 
acts as a splicing factor that limits Vegfc/Flt4 signalling. Its absence causes premature 
and excessive formation of sprouting venous EC that fail to fully differentiate into 
functional lymphatic structures due to an increase of Vegfc/Flt4/Mapk signalling and 
consequently persistent proliferation. 
 
According to current understanding, the decisive fate determining step in the formation 
of the lymphatic system in the zebrafish trunk is the acquisition of a prox1a high 
expression status in the cells of the PCV and reinforcement of the flt4 signalling in a 
majority of lymphatic precursor cells. These cells emerge from the PCV as secondary 
sprouts to form first the PLs and subsequently expand to form the TD and other trunk 
lymphatic vessels (Koltowska et al., 2015; Nicenboim et al., 2015). Recent work 
demonstrated that a secondary sprout either contribute to remodelling a pre-existing 
ISV into a vein, or form a PLs (Geudens et al., 2019). In addition, a single secondary 
sprout is able to simultaneously form a vISV and give rise to lymphatic progenitors, 
which can be seen emerging from a remodelled vISVs (Geudens et al., 2019; Isogai 
et al., 2003). Unlike in control siblings, the few PLs forming in vash-1 morphants are 
found associated with venous ISVs and often have a more vascular appearance, 
suggesting a defect in lymphatic specification. Additionally, the number of 
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PLs present appears insufficient to form the trunk lymphatic vasculature. Together 
these findings suggest that Vash-1 is of particular importance to control 
lymphangiogenesis. 
 
Vash-1 is highly conserved across eukaryotes, especially the three amino-acids that 
constitute a non-canonical Cys-His-Ser catalytic triad active site (Sanchez-Pulido & 
Ponting, 2016) that are necessary for the tubulin detyrosination function (Adamopoulos 
et al., 2019; Nieuwenhuis et al., 2017). Human and murine VASH-1 protein variants 
induce similar effects in angiogenesis assays when applied ectopically (Watanabe et 
al., 2004), suggesting similar functions across these species. Our pairwise sequence 
analysis indicates that the residues necessary for tubulin recognition and 
detyrosination (Adamopoulos et al., 2019; Nieuwenhuis et al., 2017) are conserved 
between human and zebrafish versions of Vash-1, suggesting conserved 
carboxypeptidase function. The fact that we could observe absence of microtubule 
detyrosination upon vash-1 KD, and rescue the phenotype with a human variant of 
VASH-1 mRNA further supports this hypothesis. Whilst earlier studies using gain-of-
function approaches reported anti-lymphangiogenic activities of ectopically added 
VASH-1 in the mouse cornea and in tumour conditions (Heishi et al., 2010), our loss-
of-function analysis in zebrafish suggests a selective pro-lymphangiogenic function of 
Vash-1 by supporting lympho-venous specification. Although this appears 
contradictory at first sight, a possible influence on Vegfc-mediated effects may explain 
the discrepancy. Whereas an acute inhibition of Vegfc signalling in existing lymphatic 
structures such as cornea and tumour inhibits further lymphatic growth, excessive 
Vegfc signalling during initial sprouting from the PCV interferes with lymphatic 
differentiation. This occurs in the nova2 mutant (Baek et al., 2019), and potentially also 
in the absence of Vash-1. Future work will need to establish whether and how Vash-1 
mediated detyrosination of endothelial microtubules restricts excessive Vegfc 
signalling, in some or all daughter cells during formation of secondary sprouts from the 
PCV. 
In conclusion, our work identifies Vash-1 as a conserved tubulin carboxypeptidase in 
zebrafish, with a selective role in secondary sprouting and LEC formation. We propose 
that a balance of the number of ECs sprouting from the cardinal vein is maintained by 
Vash-1 via microtubule detyrosination and consequent EC divisions and that Vash-1 
has a role in LEC specification and formation in the zebrafish trunk.  
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Figure 1. vash-1 is highly expressed in zebrafish endothelium. 
A-B Aminoacid sequence alignment by CLUSTAL O (Uniprot) of human and zebrafish 
Vash-1 showing 65,1% sequence similarity (A), including in the residues necessary for 
tubulin detyrosination (B).  
C-D Analysis of vash-1 expression in zebrafish embryos at 24 and 48hpf. FACS sorting 
and gating strategy for isolation of nEGFP+ and nEGFP- cells from Tg[fli1a:nEGFP]y7 
embryos, their RNA extraction and reverse transcription leading to qPCR (C). vash-1 
expression, analysed by two independent primer pairs, show a tendency towards being 
enriched in the endothelium of zebrafish embryos at 24hpf (D). Data normalised to 
housekeeping genes. Each data point is an average of 3 technical replicates per 
sample, and each experiment has 3 biological replicates per developmental stage. 




Figure 2. Endothelial microtubules are detyrosinated by Vash-1 in zebrafish. 
A-B Knockdown (KD) strategy using a morpholino (MO) targeting the intron3-exon4 
(A) efficiently decreases Vash-1 protein levels as detected by Western blot (B). 48 hpf 
embryo lysate was used.   
C Mechanism of tyrosine cleavage from α-tubulin carboxy-terminus by Vash-1, 
resulting in detyrosinated tubulin (dTyr). Detyrosination exposes a glutamate residue 
accessible by a homemade antibody (Liao et al., 2019).  
D-G Immuno-stainings of 48 hpf Tg[fli1ep:EGFP-DCX] embryos detect detyrosinated 
microtubules (referred as dTyr, D,F,E,G) and GFP-labelled microtubules (referred as 
DCX, D,F). G,G’ shows quantification of dTyr signal upon vash-1 KD compared with 
the control MO injected sibling embryos (E,E´). Arrows (E,G) indicate neural tube, with 
typically detyrosinated microtubules (E), reduced upon vash-1 KD (G). Arrow heads 
indicate endothelial detyrosinated microtubules, only present in control embryos (E,E‘). 
Asterisks (E,G) indicate motoneurons exhibiting high dTyr signal in control embryos 
(E,E‘) and decreased dTyr signal in vash-1 KD embryos (G,G’).  
H-J Quantifications of DCX and dTyr signal intensity of each ISV (data points) in control 
and vash-1 KD groups. H. Quantification of ratios between dTyr and DCX intensity 
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signals. Quantification of the intensity of the dTyr tubulin signal (I) and the EGFP-DCX 
signal (J) confirm that the microtubule detyrosination decreases in the ISVs whereas 
the eGFP-DCX intensity is not altered. AU stands for arbitrary units. Each data point 
is one ISV, N=100-110 ISVs from 9 embryos were quantified, in control and vash-1 KD 




Figure 3. Vash-1 deficient embryos exhibit aberrant secondary sprouting and 
increased cell proliferation. 
A-G Primary and secondary sprouting in control and vash-1 KD Tg[kdr-l:ras-Cherry]s916 
zebrafish embryos, with labelled blood vessels. Primary sprouting occurs from the 
dorsal aorta (DA) at 24–30 hours post fertilization (hpf) (A,B,C) and form inter-
segmental vessels (ISVs) (D,E,F). Secondary sprouting occurs from the posterior 
cardinal vein (PCV) at 34-40 hpf (D,E,F). Red arrowheads label secondary sprouts 
(E,F). G. Quantifications of number of secondary sprouts per 6 somites. Data points 
come from 11 embryos for vash-1 KD group, and for 6 control embryos. Mann-Whitney 
test, * = p<0.05.  
H-K Secondary sprouts in Tg[kdr-l:ras-Cherrys916,fli1a:nEGFPy7] embryos, with 
membrane- and nuclei-labelled endothelial cells (H,I) and quantification of  endothelial 
nEGFP labelled nuclei in secondary sprouts (J) and number of nuclear divisions in the 
secondary sprout (K), from 30 to 70 hpf. White arrowheads indicate nuclei in secondary 
sprouts (marked by dashed line). N=9 ISVs from 4 control embryos, n=24 ISVs from 7 
vash-1 KD embryos; P<0.0002 with t-test, ***= p<0.0002.  
L-N A transient 3-way connection is formed when the secondary sprout connects with 
the primary ISV and lumenises (L), schematically illustrated in M. N. Quantification of 
3-way connection duration in control and vash-1 MO injected embryos. Data points 
come from 28 ISVs from 9 embryos for vash-1 KD and 11 ISVs from 5 embryos for 
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Figure 4 Microtubules of secondary sprouts are selectively highly detyrosinated. 
A-I Immunostainings using antibody detecting the glutamate aminoacid of 
detyrosinated microtubules (dTyr) during primary (A-C) and secondary (D-F) sprouting 
in uninjected Tg[fli1ep:EGFP-DCX] embryos, labelling all endothelial microtubules 
(DCX). C’, F’, I’, magnification from indicated region in C,F,I, respectively. Plcγ KD 
embryos (G-I) show reduced primary sprouting, facilitating the visualization and 
quantification of dTyr signal specifically in secondary sprouts.  
J Quantification of the proportion of dTyr/DCX signal intensity in primary sprouts of 
control morpholino (MO) injected embryos, and secondary sprouts from Plcγ MO 
injected embryos. N= 37 control primary sprouts, and N= 24 Plcγ KD secondary 




Figure 5. Vash-1 regulates formation of trunk lymphatic vasculature 
A-D Tg[fli1a:EGFP]y1 labels parachordal lymphangioblasts (PLs) of control (A) and 
vash-1 KD embryos (B) at 52 hpf. Asterisks indicate PLs (A), arrowhead indicate 
putative ISV-to-ISV connection (B). C Quantification of the number of somites with PLs 
in embryos injected with control and vash-1 MO. Quantification of percentage of PLs 
connected to a venous ISV (D). The amount of somites quantified varied from 6-8, n= 
10-12 embryos per experimental group, minimum of 3 biological replicates per 
quantification, p-value was calculated using Mann-Whitney test. ****, p<0.0001, 
**=<0.02.  
 E-G Zebrafish trunk of 4 dpf Tg[kdr-l:ras-Cherrys916,fli1a:EGFPy1] zebrafish embryos. 
Arrow heads indicate GFP and mCherry positive putative ISV-to-ISV connections in 
vash-1 KD embryos (F,F’). The main axial lymphatic in the zebrafish trunk – thoracic 
duct (TD) - is GFP-positive, mCherry-negative (E,E’, labelled by an arrow), absent in 
the vash-1 KD embryo (F,F‘’). G Quantification of the number of somites with TD.  
For all quantifications (C,D,G), the amount of somites quantified varied from 6-8, n= 
10-12 embryos per experimental group, minimum of 3 biological replicates per 
quantification, p-value was calculated using Mann-Whitney test. ****, p<0.0001, 
**=<0.02.  
H-J Validation and quantification of KD experiment include confirmation of the 
phenotype with a second MO targeting a different splicing region of the vash-1 
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immature mRNA and rescue of the phenotype with mature mRNA lacking the MO 
targeting region (H). Quantification of somites with PLs upon injection of a second MO 
(MO2) targeting vash-1 (I) and co-injection of mature vash-1 mRNA in vash-1 MO1 
injected embryos (J). For all groups, 22-30 embryos, and 7-8 somites quantified. p-
value was calculated using Kruskal-Wallis test. ****, p<0.0001, **=<0.02, * = p<0.05.  
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